Free tool
FAERS Monitor: Fosrenol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204734 or its brand name (Fosrenol, Lanthanum Carbonate). Reports on generic versions are filed under their own applications.
Reports
5,132
Serious
4,599
90% of reports
Hospitalization
2,534
Death reported
1,612
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death679
- nausea504
- vomiting492
- constipation386
- sepsis381
- abdominal pain375
- off label use351
- general physical health deterioration348
- abdominal distension320
- hyponatraemia311
- multiple organ dysfunction syndrome300
- anaemia297
- stress295
- ascites288
- appendicitis278
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 68 |
| 2006 | 87 |
| 2007 | 76 |
| 2008 | 112 |
| 2009 | 296 |
| 2010 | 496 |
| 2011 | 309 |
| 2012 | 290 |
| 2013 | 214 |
| 2014 | 202 |
| 2015 | 254 |
| 2016 | 279 |
| 2017 | 284 |
| 2018 | 297 |
| 2019 | 258 |
| 2020 | 269 |
| 2021 | 329 |
| 2022 | 273 |
| 2023 | 218 |
| 2024 | 209 |
| 2025 | 169 |
| 2026 | 143 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,027 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| appendicitisSignal | 278 | 125.7 | 111.9 | 33,255 |
| multiple organ dysfunction syndromeSignal | 300 | 43.9 | 39.3 | 12,406 |
| ascitesSignal | 288 | 40.5 | 36.2 | 10,973 |
| hyponatraemiaSignal | 311 | 22.8 | 20.4 | 6,428 |
| stressSignal | 295 | 16.8 | 15.1 | 4,375 |
| sepsisSignal | 381 | 14.0 | 12.7 | 4,611 |
| abdominal distensionSignal | 320 | 12.6 | 11.3 | 3,412 |
| general physical health deteriorationSignal | 348 | 12.4 | 11.2 | 3,632 |
| constipationSignal | 386 | 7.3 | 6.6 | 2,097 |
| abdominal painSignal | 375 | 6.6 | 6.0 | 1,799 |
| anaemiaSignal | 297 | 6.4 | 5.7 | 1,355 |
| vomitingSignal | 492 | 4.3 | 3.9 | 1,266 |
| deathSignal | 679 | 3.2 | 3.0 | 1,088 |
| nauseaSignal | 504 | 2.6 | 2.4 | 519 |
| off label use | 351 | 1.6 | 1.5 | 91 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.